Transforming biotech training
Photos by Evan Krape November 25, 2024
QIAGEN partnership brings digital PCR innovation to UD, revolutionizing lab training
Undergraduate students in the University of Delaware College of Health Sciences’ Department of Medical and Molecular Sciences (MMSC) are gaining rare access to cutting-edge technology that can detect cancer mutations and infectious diseases with unparalleled precision.
The opportunity was made possible by a generous donation from QIAGEN, a global leader in molecular diagnostics based in Germany. Its contribution of a QIAcuity digital PCR System reflects the company’s commitment to fostering innovation and cultivating future leaders in health sciences.
“QIAGEN is very invested in the next generation of scientists and emerging talent we see at universities like the University of Delaware,” said Mohamed Swaraldahab, a senior digital PCR field application specialist. “UD’s MMSC program is one of few — a first-of-its-kind, really — and the quality of the students is very impressive.”
Swaraldahab recently visited Willard Hall Education Building on UD’s campus for a hands-on lecture and training session with students in the Basic Recombinant DNA Techniques class.
“You don’t know how rare it is for a university to have this technology,” Swaraldahab told the students. “Consider yourselves very lucky to have access to this technology. Digital PCR is your gateway into industry or graduate programs. If I receive a resume, and they know dPCR, I want them on my team.”
A partnership is born
Esther Biswas-Fiss, professor and chair of the MMSC Department, first met with Samir Afif, QIAGEN’s senior account manager supporting UD, over lunch a year and a half ago to discuss potential collaboration opportunities.
“I was immediately struck by the program’s unique emphasis on developing not only the intellectual capabilities of its students but also their practical bench skills,” Afif said. “Every graduate leaves with the hands-on expertise needed to make an immediate impact in any professional laboratory, which sets this program apart from others I’ve encountered.
“From the beginning, it was clear this program was an ideal match for a first-of-its-kind partnership with QIAGEN. The pharmaceutical ecosystem I support is adopting digital PCR at a rapid pace, and it’s essential for QIAGEN to invest in the next generation of scientists who will leverage this technology to bring transformative therapies to market.”
Biswas-Fiss shared with QIAGEN that while she would love to train students in dPCR, the cost of technology was a barrier. That prompted QIAGEN to donate the high-end instrument.
“It costs so much to conduct dPCR experiments, and our students get to do this, thanks to QIAGEN, which is extraordinary,” Biswas-Fiss said.
Biswas-Fiss said the technology has applications for several MMSC classes.
“Digital PCR will be used in our molecular diagnostics and cell and tissue culture courses; it has applications for gene expression,” she said. “It also has applications for masters and doctoral students to conduct cutting-edge research as we integrate the device into all our labs.”
This collaboration is just one example of how the MMSC Department innovates to ensure students are equipped with the skills and experiences needed to excel in the rapidly evolving fields of biotechnology and molecular sciences.
“As technology advances, we strive to update our curriculum,” said Biswas-Fiss. “Digital PCR gives our students unique exposure that few other students in the country have — I’m very proud of that.”
QIAGEN’s generosity doesn’t end with the donation of the dPCR instrument. In addition to the training session, the company is donating reagents needed to run experiments and plans to bring MMSC students to tour their research and development facility in Frederick, Maryland, in the spring.
“That opens up the door for our students to pursue possible internships with QIAGEN,” said Biswas-Fiss.
During a networking session that followed the training, representatives of QIAGEN continued to be impressed by the students’ experience and enthusiasm.
“Their passion and eagerness to learn made me confident that they will have a strong start when entering the job market,” said Antonina Spencer, senior manager with QIAGEN. “It made me proud to work for QIAGEN, knowing we could share this valuable experience with such a motivated group.”
“The students were bold and impressive in selling themselves and their desires for career prospects in the future,” said Megan Gallagher, field application specialist with QIAGEN. “The experience will certainly translate into opportunities for them once they enter the job market.”
A competitive edge
After a demo showcasing the precision and accuracy of the QIAcuity dPCR, Grace Davis, a junior applied molecular biology and biotechnology (AMBB) major, was in awe.
“I want to pursue a career in vaccine and medication development, so I appreciate this experience because it gives us a leg up in the industry,” Davis said.
This year, Zaina Punter, a junior AMBB major, transferred to UD from Delaware Technical Community College for opportunities like this.
“They’ve emphasized that this state-of-the-art technology isn’t often seen in undergraduate labs,” Punter said. “Knowing dPCR will put me ahead of all the undergraduates in the country whether I want to enter academia or industry.”
As they continue to master the technique, students like Davis and Punter can add dPCR to their résumés.
“This collaboration strengthens UD’s MMSC program but also sets a benchmark for innovation in undergraduate education nationwide,” said Biswas-Fiss. “When our students enter the workforce, they will be well-prepared and exceed all expectations.”
Contact Us
Have a UDaily story idea?
Contact us at ocm@udel.edu
Members of the press
Contact us at 302-831-NEWS or visit the Media Relations website